Merger expected to expand company’s existing complementary platform of organ manufacturing programs.
United Therapeutics announced in a company press release that it has agreed to terms to acquire Miromatrix Medical. Reportedly, the acquisition is expected to expand United Therapeutics’ existing complementary platform of organ manufacturing programs, which include ex-vivo lung perfusion, xenotransplantation, 3D bioprinting, and regenerative medicine approaches with the objective of creating an unlimited supply of tolerable, transplantable organs.
Under terms of the agreement, United Therapeutics will commence a tender offer to acquire all outstanding shares of Miromatrix for a purchase price of approximately $91 million and an additional $1.75 per share in cash upon the achievement of a clinical development milestone related to Miromatrix’s development-stage, fully implantable manufactured kidney product known as mirokidney by Dec. 31, 2025.
“At United Therapeutics, we are determined to rectify the severe shortage of transplantable organs,” said Martine Rothblatt, PhD, chairperson, CEO, United Therapeutics. “We expect that Miromatrix will help us in this mission, bringing a number of new approaches, highly skilled personnel, and state of the art facilities as additional shots on goal to complement our existing organ manufacturing programs.”
Reference: United Therapeutics to Acquire Miromatrix Medical. United Therapeutics. October 30, 2023. Accessed October 30, 2023. https://ir.unither.com/news/press-releases/press-release-details/2023/United-Therapeutics-to-Acquire-Miromatrix-Medical/default.aspx
Transforming Cancer Care: Data, AI, and Patient-Centered Care
July 20th 2023Join us as Mohit Manrao, SVP and head of US oncology at AstraZeneca, shares his patient-centered approach to transforming cancer care, bridging the gap between innovative science and tangible patient outcomes across all populations on a global scale.
Trends in Continuing Medical Education
April 12th 2024Elliott Yoo, Senior Media Strategist at epocrates, takes a closer look at the trends in CME consumption and what the future of medical education will be – from the priorities for physicians as they juggle learning with patient care, to what type of activities resonate most with prescribers.
Beyond the Scrubs: Understanding Healthcare Providers as People for Increased Engagement
March 28th 2024The benefits of adopting a humanized approach to healthcare provider marketing extend across the healthcare spectrum, enhancing engagement rates, brand loyalty, and marketing ROI, while also driving better outcomes for patients.